Anemia, Aplastic: all 348 studies
Page 1 of 4. Open to participants first (100), then studies with results posted, then the rest; newest registration first within each.
- Conditioning Regimen Containing Low-Dose ATG for the Treatment of AA Receiving sUCBTNot yet recruitingNCT07885982Phase 2
- Thiotepa-Based Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation in Older Patients With Severe Aplastic AnemiaNot yet recruitingNCT07819812
- Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNINot yet recruitingNCT07796620Phase 1/2
- A Study of Avatrombopag in Adults With Aplastic Anemia Who Did Not Respond to, Cannot Receive, or Had Return of Disease After Standard TreatmentNot yet recruitingNCT07786922Phase 2/3
- Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anemia PatientsNot yet recruitingNCT07737262Phase 3
- Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic AnemiaRecruitingNCT07714512Phase 1/2
- A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure SyndromesNot yet recruitingNCT07712562Phase 1/2
- Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell TransplantationNot yet recruitingNCT07698080Phase 2
- Peripheral Blood Versus Bone Marrow Plus Peripheral Blood Grafts for Haploidentical Transplantation in Severe Aplastic AnemiaRecruitingNCT07629947Not applicable
- A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAARecruitingNCT07586735
- Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRSRecruitingNCT07578675
- Romiplostim N01 in Chemoradiotherapy-induced Aplastic AnemiaNot yet recruitingNCT07572084Phase 2
- CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAANot yet recruitingNCT07558434Phase 2
- Clinical Study on the Preservation of Ovarian Function in Patients With Aplastic Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation Using GoserelinNot yet recruitingNCT07552506Not applicable
- A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic AnemiaRecruitingNCT07499284Not applicable
- CK0801 for Treatment of Aplastic AnemiaNot yet recruitingNCT07499102Phase 2
- Adverse Effects of ATG/ALG Therapy in Aplastic AnemiaRecruitingNCT07461116
- Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AARecruitingNCT07400341Phase 2
- HID-HSCT Versus IST as First-line Treatment for SAANot yet recruitingNCT07338422Not applicable
- Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAAEnrolling by invitationNCT07299123Phase 1/2
- Safety and Efficacy of the JAK1 Inhibitor Combined With Intensive Immunosuppressive Therapy in Severe Aplastic AnemiaNot yet recruitingNCT07297550Phase 1/2
- The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic AnemiaNot yet recruitingNCT07287228Phase 1/2
- The HOPE Biobank Resource (BMT CTN 2402 HOPE)RecruitingNCT07227155
- High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)RecruitingNCT07205523
- HPC Offered for PRESERVE ExpansionRecruitingNCT07145411
- Assesment of Treatment Outcomes of Aquired Aplastic Anemia in Children : A Retrospective and Prospective CohortNot yet recruitingNCT07131878
- Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research StudyEnrolling by invitationNCT07102849
- A Prediction Model in Pregnant Women With Aplastic AnemiaRecruitingNCT07101770
- Efficacy and Safety of UCBT With TMI -Based Conditioning Regimen for Adults With Refractory/Relapsed Aplastic AnemiaNot yet recruitingNCT07078721Phase 2
- Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic AnemiaRecruitingNCT07010237Phase 2
- Study on the Short-term Efficacy and Safety of Recombinant Human Thrombopoietin Combined With Immunosuppressant Sequential Eltrombopag Ethanolamine Dry Suspension in the Treatment of SAA/TD-NSAANot yet recruitingNCT07001397Phase 3
- Treatment of Transfusion-dependent Nonsevere Aplastic Anemia With Luspatercept: a Multicenter Prospective Clinical StudyNot yet recruitingNCT06964971Not applicable
- Reproductive and Mental Health of Patients With Aplastic AnemiaRecruitingNCT06936930
- Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin ARecruitingNCT06802055Phase 2
- Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic AnemiaNot yet recruitingNCT06791824Phase 1/2
- Reduced-dose Conditioning Regimen Containing TBI in HSCT Treating Elderly Patients With Aplastic AnemiaNot yet recruitingNCT06769568Phase 2
- Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic AnemiaRecruitingNCT06695741Phase 2
- Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular TherapyRecruitingNCT06689800Not applicable
- Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment StudyRecruitingNCT06650553Not applicable
- Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 YearsRecruitingNCT06646497Phase 2
- CD7 CAR-T Bridging to alloHSCT for Severe Aplastic AnemiaRecruitingNCT06633328Early Phase 1
- CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic AnemiaRecruitingNCT06622694Phase 1
- Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic AnemiaRecruitingNCT06613880Phase 2
- REscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transplantation 2Not yet recruitingNCT06607367Phase 1/2
- A Study of Romiplostim for the Treatment of Refractory Transfusion-dependent NSAANot yet recruitingNCT06535685Phase 4
- Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAANot yet recruitingNCT06525948Phase 4
- NAC for Hematopoietic Recovery in SAANot yet recruitingNCT06518044Phase 2
- Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic AnemiaRecruitingNCT06517641Phase 2
- Ropustin for Refractory Aplastic Anaemia After Radiotherapy - a Single-centre, Prospective, Open-label, Single-arm StudyNot yet recruitingNCT06516484Phase 4
- Outcomes in Bone Marrow Aplasia.Not yet recruitingNCT06493981Phase 3
- Effects of Levetiracetam Monotherapy on Various Hematological Parameters in Adult Patients Suffering of EpilepsyNot yet recruitingNCT06491303
- A Study of Emapalumab for Pediatric Aplastic AnemiaRecruitingNCT06430788Phase 2
- A Prospective Study on the Treatment of Recurrent/Refractory/Intolerable NSAA With LusutrombopagNot yet recruitingNCT06426043Phase 4
- MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.RecruitingNCT06412497Phase 2
- Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesRecruitingNCT06398457Early Phase 1
- Clinical Study on Modified Allogeneic Hematopoietic Stem Cell Transplantation Regimen for Severe Aplastic AnemiaRecruitingNCT06378060Phase 2
- Total Body Irradiation Treatments for Patients Treated at European Institute of OncologyRecruitingNCT06335277
- Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative NeoplasmsRecruitingNCT06303193Phase 1/2
- Revolade Tablets Specified Drug-use SurveyRecruitingNCT06287268
- Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin InhibitorsNot yet recruitingNCT06279494Phase 1/2
- Rituximab for Serious Aplastic Anemia With Platelet Transfusion RefractorinessRecruitingNCT06254560Phase 2
- Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of SAANot yet recruitingNCT06254287Phase 2
- RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)RecruitingNCT06213402
- The Optimization of Conditioning Regimen for HLA Matched HSCT in SAARecruitingNCT06069180Phase 4
- Conditioning Regimen Containing Low Dose ATG for The Treatment of Acquired SAA Receiving sUCBTRecruitingNCT06039436
- Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction SystemRecruitingNCT06009965Phase 4
- Romiplostim in Combination With CsA vs. CsA in the Treatment of Newly Diagnosed NSAANot yet recruitingNCT06009497Phase 4
- A Prospective, Randomized, Controlled Study of rhTPO in Combination With Herombopag + CsA vs Herombopag + CsA for the Treatment of Primary TD-NSAANot yet recruitingNCT06004791Phase 4
- Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the ElderlyRecruitingNCT06004752Phase 2
- Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment of Non-severe Aplastic AnemiaRecruitingNCT05797623Phase 2
- Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure DisordersRecruitingNCT05794425Phase 1/2
- A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic AnemiaRecruitingNCT05757310Phase 1
- The Safety and Efficacy Study of Avatrombopag Switch in TPO-RA Refractory AARecruitingNCT05518331Not applicable
- GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCTRecruitingNCT05510505Phase 2
- Up-front Matched Unrelated Donor Transplantation in Pediatric Patients With Idiopathic Aplastic AnemiaNot yet recruitingNCT05419843Phase 2
- Autologous Tregs for Aplastic AnaemiaRecruitingNCT05386264Phase 1
- An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AANot yet recruitingNCT05333861
- Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT SurvivorsRecruitingNCT05194397Phase 2
- Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After ImmunosuppressionRecruitingNCT05126849Phase 2
- RACE 2: a Long Term Follow-up of Patients Participating in the RACE TrialEnrolling by invitationNCT05049668
- Two Step Haplo With Radiation ConditioningRecruitingNCT05031897Phase 2
- Natural History of Acquired and Inherited Bone Marrow Failure SyndromesRecruitingNCT05012111
- Managed Access Programs for ETB115, EltrombopagAvailableNCT04837703
- French National Registry of Bone Marrow FailuresRecruitingNCT04781790
- National Longitudinal Cohort of Hematological DiseasesRecruitingNCT04645199
- Haploidentical HCT for Severe Aplastic AnemiaRecruitingNCT04558736Phase 2
- TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in ChildrenRecruitingNCT04356469Phase 2
- Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)RecruitingNCT04304820Phase 2Results posted
- AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell DepletionRecruitingNCT04099966Phase 2
- Alpha/Beta TCD HCT in Patients With Inherited BMF DisordersRecruitingNCT03579875Phase 2
- Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD ProphylaxisRecruitingNCT03520647Phase 2
- Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant OutcomeRecruitingNCT03173937Phase 1/2
- Umbilical Cord Blood Transplantation From Unrelated DonorsRecruitingNCT03016806
- Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic AnemiaRecruitingNCT02828592Phase 2
- Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood TransplantsAvailableNCT01881334
- Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic SyndromeRecruitingNCT01624805Phase 2
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)RecruitingNCT01351545
- Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cellsRecruitingNCT01174108Phase 2
- Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerRecruitingNCT01137643
- Cancer in Inherited Bone Marrow Failure SyndromesRecruitingNCT00027274